These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32894823)

  • 1. Anticancer activity of topical ointments with histone deacetylase inhibitor, trichostatin A.
    Chodkowska A; Bieńkowska A; Słyk Ż; Giebułtowicz J; Małecki M
    Adv Clin Exp Med; 2020 Sep; 29(9):1039-1049. PubMed ID: 32894823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo.
    Vigushin DM; Ali S; Pace PE; Mirsaidi N; Ito K; Adcock I; Coombes RC
    Clin Cancer Res; 2001 Apr; 7(4):971-6. PubMed ID: 11309348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semisolid formulations containing dimethyl sulfoxide and alpha-tocopherol for the treatment of extravasation of antiblastic agents.
    Casiraghi A; Ardovino P; Minghetti P; Botta C; Gattini A; Montanari L
    Arch Dermatol Res; 2007 Jul; 299(4):201-7. PubMed ID: 17370081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro permeation profile of a local anaesthetic compound from topical formulations with different rheological behaviour--verified by in vivo efficacy data.
    Welin-Berger K; Neelissen J; Bergenståhl B
    Eur J Pharm Sci; 2001 Oct; 14(3):229-36. PubMed ID: 11576828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trichostatin A Ameliorates Conjunctival Fibrosis in a Rat Trabeculectomy Model.
    Sung MS; Eom GH; Kim SJ; Kim SY; Heo H; Park SW
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3115-3123. PubMed ID: 30025124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-transcriptomic Profile of SK-MEL-3 Melanoma Cells Treated with the Histone Deacetylase Inhibitor: Trichostatin A.
    Mazzio EA; Soliman KFA
    Cancer Genomics Proteomics; 2018; 15(5):349-364. PubMed ID: 30194076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of additives on release and in vitro skin retention of flavonoids from emulsion and gel semisolid formulations.
    Dyja R; Jankowski A
    Int J Cosmet Sci; 2017 Aug; 39(4):442-449. PubMed ID: 28267214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo efficacy and properties of semisolid formulations containing panthenol.
    Pavlačková J; Egner P; Sedláček T; Mokrejš P; Sedlaříková J; Polášková J
    J Cosmet Dermatol; 2019 Feb; 18(1):346-354. PubMed ID: 29577586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of creams and ointments as suitable formulations for peldesine.
    Viegas TX; Van Winkle LL; Lehman PA; Franz SF; Franz TJ
    Int J Pharm; 2001 May; 219(1-2):73-80. PubMed ID: 11337167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ointment bases on topical and transdermal delivery of salicylic acid in rats: evaluation by skin microdialysis.
    Murakami T; Yoshioka M; Okamoto I; Yumoto R; Higashi Y; Okahara K; Yata N
    J Pharm Pharmacol; 1998 Jan; 50(1):55-61. PubMed ID: 9504435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells.
    Park KC; Heo JH; Jeon JY; Choi HJ; Jo AR; Kim SW; Kwon HJ; Hong SJ; Han KS
    BMC Cancer; 2015 Jan; 15():19. PubMed ID: 25613585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility and radiosensitization of human glioblastoma cells to trichostatin A, a histone deacetylase inhibitor.
    Kim JH; Shin JH; Kim IH
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1174-80. PubMed ID: 15234053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model.
    Nasu Y; Nishida K; Miyazawa S; Komiyama T; Kadota Y; Abe N; Yoshida A; Hirohata S; Ohtsuka A; Ozaki T
    Osteoarthritis Cartilage; 2008 Jun; 16(6):723-32. PubMed ID: 18226559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitors trichostatin A and suberoylanilide hydroxamic acid attenuate ventilator-induced lung injury.
    Chen HY; Li L; Fu ZJ
    Pharmazie; 2014 Jan; 69(1):55-9. PubMed ID: 24601225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibitors and paclitaxel cause synergistic effects on apoptosis and microtubule stabilization in papillary serous endometrial cancer cells.
    Dowdy SC; Jiang S; Zhou XC; Hou X; Jin F; Podratz KC; Jiang SW
    Mol Cancer Ther; 2006 Nov; 5(11):2767-76. PubMed ID: 17121923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone Deacetylase Inhibitor Trichostatin A Ameliorated Endotoxin-Induced Neuroinflammation and Cognitive Dysfunction.
    Hsing CH; Hung SK; Chen YC; Wei TS; Sun DP; Wang JJ; Yeh CH
    Mediators Inflamm; 2015; 2015():163140. PubMed ID: 26273133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
    Duo J; Ma Y; Wang G; Han X; Zhang C
    DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomes loaded with histone deacetylase inhibitors for breast cancer therapy.
    Urbinati G; Marsaud V; Plassat V; Fattal E; Lesieur S; Renoir JM
    Int J Pharm; 2010 Sep; 397(1-2):184-93. PubMed ID: 20603204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis.
    Hemmatazad H; Rodrigues HM; Maurer B; Brentano F; Pileckyte M; Distler JH; Gay RE; Michel BA; Gay S; Huber LC; Distler O; Jüngel A
    Arthritis Rheum; 2009 May; 60(5):1519-29. PubMed ID: 19404935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trichostatin A, an inhibitor of histone deacetylase, inhibits hypoxia-induced angiogenesis.
    Williams RJ
    Expert Opin Investig Drugs; 2001 Aug; 10(8):1571-3. PubMed ID: 11785457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.